BEST of ASCO Portugal 2024 - ARM
Abstract
The American Society of Clinical Oncology (ASCO) 2024 Annual Meeting highlighted several developments in supportive care, emphasizing innovative approaches to enhance care through novel interventions and personalized symptom management. This narrative review synthesizes and critically evaluates four of the main studies in supportive care presented: “REACH PC Trial: Comparative effectiveness trial of early palliative care delivered via telehealth versus in person among patients with advanced lung cancer” by Greer J, et al; “MENAC Trial: Results from a randomized, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy” by Solheim T, et al; “MC2 Trial: A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care” by Hardy J, et al; and “Alliance A222001 Trial: A randomized, double-blind, placebo controlled phase II study of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy” by Stish B, et al. The aim is to provide a comprehensive overview of studies that address symptom management and quality of life (QoL), while emphasizing the clinical implications of the results presented.
Downloads
References
Joseph A. Greer et al. Comparative effectiveness trial of early palliative care delivered via telehealth versus in person among patients with advanced lung cancer. JCO 42, LBA3-LBA3(2024). DOI:10.1200/JCO.2024.42.17_suppl.LBA3
Tora S. Solheim et al. Results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy. JCO 42, LBA12007- LBA12007(2024). DOI:10.1200/JCO.2024.42.17_suppl.LBA12007
Janet Rea Hardy et al. A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care. JCO 42, 12020-12020(2024). DOI:10.1200/JCO.2024.42.16_suppl.12020
Brad J. Stish et al. Alliance A222001: A randomized, double-blind, placebo controlled phase II study of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy. JCO 42, LBA12004-LBA12004(2024). DOI:10.1200/JCO.2024.42.17_suppl.LBA12004
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678. PMID: 20818875.
Shaffer KM, Turner KL, Siwik C, Gonzalez BD, Upasani R, Glazer JV, Ferguson RJ, Joshua C, Low CA. Digital health and telehealth in cancer care: a scoping review of reviews. Lancet Digit Health. 2023 May;5(5):e316-e327. doi: 10.1016/S2589-7500(23)00049-3.
Argilés JM, López-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023 Apr;20(4):250-264. doi: 10.1038/s41571-023-00734-5.
Crawford J, Calle RA, Collins SM, Weng Y, Lubaczewski SL, Buckeridge C, Wang EQ, Harrington MA, Tarachandani A, Rossulek MI, Revkin JH. A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia. Clin Cancer Res. 2024 Feb 1;30(3):489-497. doi: 10.1158/1078-0432.CCR-23-1631.
Braun IM, Bohlke K, Abrams DI, Anderson H, Balneaves LG, Bar-Sela G, Bowles DW, Chai PR, Damani A, Gupta A, Hallmeyer S, Subbiah IM, Twelves C, Wallace MS, Roeland EJ. Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline. J Clin Oncol. 2024 May 1;42(13):1575-1593. doi: 10.1200/JCO.23.02596.
Worster B, Hajjar ER, Handley N. Cannabis Use in Patients With Cancer: A Clinical Review. JCO Oncol Pract. 2022 Nov;18(11):743-749. doi: 10.1200/OP.22.00080.
Nguyen PL, Alibhai SM, Basaria S, D'Amico AV, Kantoff PW, Keating NL, Penson DF, Rosario DJ, Tombal B, Smith MR. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol. 2015 May;67(5):825-36. doi: 10.1016/j.eururo.2014.07.010.
